Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Anti-androgens might help reduce COVID-19 severity in men.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

ERG increases SOX9, promoting prostate cancer growth and invasion.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Higher androgen levels might make COVID-19 worse, especially in men.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

Sex hormones may affect COVID-19 severity and outcomes.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Genetic differences affect COVID-19 severity and treatment development.

Antiandrogens don't help with COVID-19 and aren't recommended.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

The ACE1 gene variant doesn't affect long-COVID symptoms.